Publications by authors named "Daiki Iguchi"

Claim this Profile
T
Thrombotic Microangiopathy in Renal Allograft Induced by Valproic Acid Treatment in Addition to Tacrolimus and Everolimus: A Case Report.
Azusa Kobayashi, Asami Takeda, Shoji Saito, Hibiki Shinjo, Daiki Iguchi

Nephron· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Pathological Course of Recurrent C3 Glomerulonephritis from Onset to Graft Loss: A Case Report.
Azusa Kobayashi, Asami Takeda, Shoji Saito, Hibiki Shinjo, Daiki Iguchi

Case Rep Nephrol Dial· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Light Chain Deposition Disease Recurrence in Renal Allograft after Long-Term Remission.
Azusa Kobayashi, Asami Takeda, Hibiki Shinjo, Daiki Iguchi, Chiharu Ito

Nephron· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term peritoneal dialysate exposure modulates expression of membrane complement regulators in human peritoneal mesothelial cells.
Kazuma Kobayashi, Toshikazu Ozeki, Hangsoo Kim, Masaki Imai, Hiroshi Kojima, Daiki Iguchi

Front Med (Lausanne)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis.
Toshikazu Ozeki, Masashi Mizuno, Daiki Iguchi, Hiroshi Kojima, Hangsoo Kim

Am J Physiol Renal Physiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment.
Takeyuki Hiramatsu, Hiroki Ito, Shota Okumura, Yuko Asano, Daiki Iguchi

Diab Vasc Dis Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients.
Takeyuki Hiramatsu, Shota Okumura, Yuko Asano, Masatsuna Mabuchi, Daiki Iguchi

Ther Apher Dial· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal.
Daiki Iguchi, Masashi Mizuno, Yasuhiro Suzuki, Fumiko Sakata, Shoichi Maruyama

Am J Physiol Renal Physiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liraglutide relieves cardiac dilated function than DPP-4 inhibitors.
Takeyuki Hiramatsu, Yuko Asano, Masatsuna Mabuchi, Kentaro Imai, Daiki Iguchi

Eur J Clin Invest· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients.
Masashi Mizuno, Yasuhiro Suzuki, Keiko Higashide, Yumi Sei, Daiki Iguchi

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.
Takeshi Terabayashi, Yasuhiko Ito, Masashi Mizuno, Yasuhiro Suzuki, Hiroshi Kinashi, Daiki Iguchi

Lab Invest· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy.
Yumi Sei, Masashi Mizuno, Yasuhiro Suzuki, Masaki Imai, Keiko Higashide, Daiki Iguchi

Mol Immunol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis